Drug Executive Collapses During Oval Office Press Conference
During a White House press event announcing a deal to lower obesity drug prices, a drug executive suddenly fainted in the Oval Office. President Donald Trump was speaking alongside leaders from pharmaceutical companies Eli Lilly and Novo Nordisk.
Details of the Incident
The press conference was interrupted when Gordon Findlay, global brand director for Novo Nordisk, collapsed. David Ricks, CEO of Eli Lilly, noticed and asked,
“Are you okay? Gordon, are you okay?”
Dr. Mehmet Oz quickly responded, assisting Findlay as he fell to his knees. The media were then asked to leave the room temporarily.
Context of the Announcement
The event focused on a partnership between Eli Lilly, Novo Nordisk, and the administration aimed at expanding coverage and reducing the cost of obesity treatments Zepbound and Wegovy.
Aftermath and Update
Health and Human Services Secretary was present during the incident. About 30 minutes later, the press conference resumed, and President Trump provided an update on Findlay's condition.
“President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help Gordon Findlay of Novo Nordisk.”
Author’s summary: A sudden collapse of a Novo Nordisk executive briefly halted a major drug pricing announcement involving President Trump and notable pharmaceutical leaders, highlighting the intense nature of the event.